Trademarkia Logo

Canada

C$
Trademark Search in Canada
CAPSIDA BIOTHERAPEUTICS

View On IC.GC.CA

CAPSIDA BIOTHERAPEUTICS
REGISTERED

on 12 Feb 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

CAPSIDA BIOTHERAPEUTICS INC.

1300 Rancho Conejo BoulevardThousand Oaks CA 91320

US

Serial Number

2099699 filed on 6th Jan 2021

Registration Number

TMA1221155 registered on 12th Feb 2024

Registration expiry Date

6th Jan 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

CAPSIDA BIOTHERAPEUTICS

Trademark usage description

pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene therapy for the treatment of genetic diseases and dis Read More

Classification Information

Class [001]
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for development of therapeutics for use in the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders.

Classification kind code

11

Class [005]
Pharmaceutical preparations for use in gene therapy; Pharmaceutical preparations for use in gene therapy for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in gene delivery technology for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of gene therapy treatable diseases and disorders; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders, and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders, and complications associated therewith; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of genetic diseases and disorders

Classification kind code

11

Class [040]
Biomanufacturing, namely, custom manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; custom manufacture of nano scale material for use in the manufacture of other goods; custom manufacturing of pharmaceutical preparations for use in gene therapy; custom manufacturing of pharmaceutical preparations for use in gene delivery technology; custom manufacturing of pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; custom manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system; custom manufacturing of pharmaceutical preparations for the treatment of cancer; custom manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer.

Classification kind code

11

Class [042]
Pharmaceutical research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; custom development of biochemical reagents, namely, design and development for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development in the field of gene therapy; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical, scientific, pharmaceutical research and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; biomedical, scientific, and pharmaceutical research and development services in the fields of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; genetic engineering services; scientific research in the field of gene therapy.

Classification kind code

11

Class [044]
Medical services in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services in the field of gene therapy via a global computer network; providing health and medical information about genetic disorders; information services, namely, providing medical information to patients in the field of genetic disorders; providing patient support services relating to cancer and cancer treatment in the nature of an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information services, namely, providing medical consultancy and advisory services via a global computer network in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing information services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures in the fields of genetic disorders and gene therapy from medical personnel

Classification kind code

11

Mark Details

Serial Number

2099699

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 29th Jul 2022		Search Recorded
Submitted for opposition 20
on 29th Jul 2022		Examiner's First Report
Submitted for opposition 223
on 29th Jul 2022		Total Provisional Refusal
Submitted for opposition 135
on 11th May 2022		Amendment to Application
Submitted for opposition 256
on 15th Feb 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Apr 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 14th Apr 2021		Formalized
Submitted for opposition 1
on 14th Apr 2021		Created
Submitted for opposition 228
on 6th Jan 2021		International Registration
Submitted for opposition 30
on 6th Jan 2021		Filed